600513.SS
Jiangsu Lianhuan Pharmaceutical Co., Ltd. [600513.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600513.SS Stock Summary
Top 10 Correlated ETFs
600513.SS
Top 10 Correlated Stocks
600513.SS
In the News
600513.SS Financial details
Company Rating
-
Market Cap
2.55B
Income
135.01M
Revenue
2.17B
Book val./share
-
Cash/share
-
Dividend
0.15
Dividend %
1.41%
Employees
1.3K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2021
P/E
22.29
Forward P/E
-
PEG
-45.86
P/S
1.49
P/B
2.23
P/C
-
P/FCF
-26.34
Quick Ratio
0.78
Current Ratio
1.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.48
EPS next Y
-
EPS next Q
-
EPS this Y
-6%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.91%
Revenue last 5Y
11%
Revenue Q/Q
30.63%
EPS Q/Q
67.19%
-
-
-
-
SMA20
11.11%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
5%
ROE
10%
ROC
0.11%
Gross Margin
51%
Oper. Margin
8%
Profit Margin
6%
Payout
39%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6.71-14.4
52W High
-30.93%
52W Low
+61.17%
RSI
61
Rel Volume
1.07
Avg Volume
7.95M
Volume
8.49M
Perf Week
5.11%
Perf Month
7.92%
Perf Quarter
-9.46%
Perf Half Y
-9.96%
-
-
-
-
Beta
0.409
-
-
Volatility
0.19%, 0.26%
Prev Close
-1.53%
Price
9.67
Change
-1.02%
600513.SS Financial Performance
600513.SS Frequently Asked Questions
What is Jiangsu Lianhuan Pharmaceutical Co., Ltd. stock symbol ?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 600513.SS
What is Jiangsu Lianhuan Pharmaceutical Co., Ltd. stock quote today ?
Jiangsu Lianhuan Pharmaceutical Co., Ltd. stock price is $9.67 today.
Is Jiangsu Lianhuan Pharmaceutical Co., Ltd. stock public?
Yes, Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 7.95M
- Market Capitalization 2.55B
- Employee 1.3K
- CEO Mr. Ben Niu
- Headquarters Yangzhou,CN
- IPO Date 2003-03-19
-
Website
https://www.lhpharma.com 
Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells chemical raw materials, preparations, and organic intermediates in China. The company offers cardiovascular, anti-allergic, urinary, anti-infective, and immunomodulatory products. The company was founded in 2000 and is headquartered in Yangzhou, China.
